To argue for a shift in research focus towards early-life prevention of metabolic disorders associated with catch-up growth, particularly through the use of natural products, emphasizing the significance of this approach.
Key Findings:
Excessive post-stunting growth is linked to insulin resistance, central obesity, and type 2 diabetes.
Catch-up growth occurs in a metabolically altered context, increasing long-term cardiometabolic risk.
Natural products, such as polyphenols and flavonoids, may offer safe and effective strategies for early-life metabolic interventions.
Interpretation:
Catch-up growth should be viewed as a critical period for metabolic intervention, emphasizing its potential for long-term health benefits.
Limitations:
Much mechanistic evidence is derived from animal models, which may not fully translate to human outcomes.
The relationship between catch-up growth and metabolic risk is complex and influenced by various environmental factors, necessitating more human studies.
Conclusion:
Reorienting research towards early-life interventions using natural bioactive compounds may help mitigate long-term metabolic consequences of childhood stunting, with significant implications for public health.
Revised American Heart Association statement urges a shift toward plant-based protein and flags ongoing uncertainty in fat and alcohol recommendations.
